Oncosil Medical Ltd has released a press release.
Clarification Of Non-Renouncable Entitlement Offer Details
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- OncoSil Launches $10m Capital Raising
- OncoSil Signs Commercial Agreement With Hospital In Spain
- First Commerical Pancreas Treatment In Spain
- Fully-Funded Trial Approved In Germany
- Half Yearly Report Results
Later from OncoSil Medical
- OncoSil Entitlement Offer Booklet
- Entitlement Offer Results and Shortfall Notification
- OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC
- FY 2023 Strategic Update
- Bupa UK Approves Reimbursement for OncoSil in the UK
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical